Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/13 → 6/30/16 |
Funding
- Mast Therapeutics, Inc.
ANX 188 Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC): A phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial of ANX-188 injection in Children with Sickle Cell disease experienci
- Thompson, Alexis A (PD/PI)
Project: Research project